09|09|26

AI Is Reshaping How Patients Find Health Information

A new article from World of DTC Marketing highlights findings from our 2026 Pharma AI Overviews Report, revealing how AI is rapidly becoming patients' first stop for health information and reshaping the traditional path to pharma and healthcare websites. Read the blog to explore what this shift means for marketers and how brands can stay ahead as search behavior evolves.

09|02|26

Beyond AI-Enabled: Why a New Partner Model Is Vital for Pharmaceutical Marketing in Europe

European pharmaceutical marketers are navigating a uniquely complex landscape, balancing diverse healthcare systems, regulatory environments and market-specific needs. As AI continues to transform commercialization, the conversation must move beyond efficiency gains and automation toward a more fundamental question: what should the future client-agency partnership look like? In this POV, Michael Le Brocq, Global Head of […]

08|31|26

Beyond the Single Click-Out: Snapchat Opens the Door to Branded Rx

For years, pharmaceutical marketers have faced a challenge on Snapchat: balancing engaging branded content with the disclosure requirements necessary for compliant Rx advertising. That may be changing. In a new POV, Ali Hudson, Media Director, Paid Social, and Juniper Valeo, Director, Social Media, explore Snapchat’s newly announced multi-CTA attachments product, which allows brands to pair […]

08|06|26

What ChatGPT Ads Mean for Pharma Search

Explore the critical differences between ChatGPT Ads and standard search, the unique regulatory challenges ahead, and the exact steps pharma brands must take now to prepare for inevitable platform access.

08|04|26

From Outputs to Outcomes: Mike Guarino on the Future of Commercialization

What does it take to be a true "category of one" in today's rapidly evolving healthcare landscape? In this Fierce Pharma interview, EVERSANA INTOUCH CEO Mike Guarino discusses the shift from outputs to outcomes, the growing role of AI in commercialization, and why the competitive advantage isn't data alone, but the stories it helps brands tell. Watch the interview excerpt to hear his perspective on the future of healthcare commercialization.

07|30|26

Preparing for FDA’s Proposed DTC Broadcast Overhaul

A proposed FDA rule could significantly reshape the future of direct-to-consumer (DTC) pharmaceutical advertising, prompting life sciences brands to rethink how they reach and engage patients. In our latest point of view, Dave Leitner, EVP, Head of Media, explores the potential impact of the FDA’s proposal to eliminate the long-standing “adequate provision” standard for broadcast […]

07|29|26

Omnideployment: The Future of Pharmaceutical Commercialization

Discover how omnideployment is helping pharmaceutical organizations connect digital engagement, AI-powered content and field execution to drive smarter HCP interactions, stronger engagement and better outcomes.

07|16|26

Webinar Recap: What Pharma Can Learn From Cannes Lions 2026

What can pharma marketers learn from the most awarded creative work in the world? Watch the recording of our recent Cannes Lions webinar to discover the standout campaigns, emerging themes and practical lessons shaping the future of marketing.

07|09|26

Human Scarcity in an AI-First World: Cannes Lions 2026

In a world flooded with AI-generated content, the brands that stand out are proving their humanity. Discover five insights from Cannes Lions 2026 that every pharma marketer should know.

07|06|26

Beyond the AI Hype: Why Authentic Connection Dominated Cannes 2026

At Cannes Lions 2026, the conversation wasn't about replacing humans with AI—it was about amplifying what makes us human. Susan Perlbachs, Chief Creative Officer, explores the rise of Human Maxing and the lessons shaping the future of creativity.